Evaxion A (EVAX) Long-Term Debt Issuances (2022)

Evaxion A (EVAX) posted Long-Term Debt Issuances of $7.8 million for Q1 2022.

Evaxion A (EVAX) Long-Term Debt Issuances (2022) Analysis & Trends

Evaxion A's Long-Term Debt Issuances history runs 1 years deep, the most recent figure standing at $7.8 million for Q1 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Issuances (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Evaxion A 25.44 Mn 25.44 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2022 7.85 Mn
Mar 31, 2022 7.85 Mn